ClinicalTrials.govpublic full text
Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination With KL-A167 for Neoadjuvant Treatment of Triple-Negative Breast Cancer
breast cancer, triple negative, sac-tmt, skb264, kl-a167, neoadjuvant, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 881241
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.